We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
Read MoreHide Full Article
Key Takeaways
HealthEquity shares gained 15.7% in three months as HSA accounts, assets, earnings and margins improved.
HQY raised fiscal 2027 revenue and adjusted EBITDA guidance after stronger second-quarter performance.
HealthEquity faces cybersecurity, pricing and interest-rate risks despite continued HSA and investment growth.
HealthEquity, Inc.(HQY - Free Report) shares have gained 15.7% in the past three months, putting the focus on whether improving fundamentals can support further upside. HSA accounts and assets advanced, second-quarter fiscal 2027 results topped expectations and margins expanded.
Management also raised fiscal 2027 revenue and adjusted EBITDA guidance. Still, cybersecurity litigation, regulatory inquiries, competitive pricing pressure and sensitivity of custodial economics to interest rates and contract renewals keep the risk-reward picture balanced after the recent advance.
HQY’s HSA Engine Keeps Building Scale
HealthEquity administered 10.7 million HSAs and $37.9 billion in HSA assets as of July 31, 2026. Those figures were up 8% and 14% year over year, respectively, reinforcing the scale of the company’s core HSA platform.
New HSAs from sales increased 24% in the fiscal second quarter. Client renewals remained on pace to exceed 90% for the year, supporting continued account growth through partner, direct and existing-client channels.
Image Source: Zacks Investment Research
HealthEquity’s Investment Balances Add Momentum
HSAs with investments rose 20% year over year to 939,000, while HSA investment assets increased 28% to $20.6 billion. The faster growth in invested assets points to greater use of the investment side of the platform.
Management said roughly 9% of HealthEquity’s HSA population was investing at quarter-end. Its recently launched SimplyInvest lineup has no administrative fee, giving the company another tool to encourage adoption as accounts mature.
HQY’s Earnings and Margins Strengthen the Setup
Adjusted earnings of $1.24 per share in the fiscal second quarter increased 14.8% year over year and beat the Zacks Consensus Estimate by 4.2%. Revenues rose 7.6% to $350.7 million and exceeded the consensus mark.
Gross margin expanded about 220 basis points to 73.5%, while operating margin improved about 60 basis points to 28.1%. Lower service costs from technology-enabled efficiencies supported the margin gains.
HealthEquity Raises Guidance as Efficiency Improves
HealthEquity raised fiscal 2027 revenue guidance to $1.411-$1.421 billion from $1.410-$1.420 billion. Adjusted EBITDA is now expected to be $628-$636 million, up from the prior $625-$633 million range.
AI resolved 85% of routine chat inquiries and contained 55% of card-related phone contacts in the latest quarter. Human-handled calls declined 25% year over year, while adjusted EBITDA margin reached 48%.
Image Source: Zacks Investment Research
HQY Still Faces Risks After the Recent Rally
The fiscal 2025 cybersecurity incident remains an overhang. HealthEquity is subject to a consolidated putative class action and regulatory inquiries, while the potential loss tied to the matters was not reasonably estimable. Custodial economics also remain sensitive to interest rates and contract renewals.
WEX Inc. (WEX - Free Report) offers HSAs and other consumer-directed benefits and serves as an IRS-designated non-bank HSA custodian. UnitedHealth Group Incorporated (UNH - Free Report) , through Optum Financial and Optum Bank, also operates at scale in health financial accounts. These alternatives underscore competition around pricing, products and partner relationships.
HQY’s Style Scores Support a Balanced View
The recent rally has support from rising HSA scale, deeper investment engagement, better quarterly profitability and higher guidance. The next test is whether HealthEquity can sustain those trends while managing cybersecurity, pricing and interest-rate risks.
HQY currently carries a Zacks Rank #3 (Hold). It has a Growth Score of B, Momentum Score of B and VGM Score of B, while its Value Score of C is less favorable. Style Scores complement the Zacks Rank, and A or B grades are generally more favorable than C. The combination supports a measured view rather than a top-ranked buy signal after the stock’s advance.
View the Zacks #1 Rank List
Image: Bigstock
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
Key Takeaways
HealthEquity, Inc.(HQY - Free Report) shares have gained 15.7% in the past three months, putting the focus on whether improving fundamentals can support further upside. HSA accounts and assets advanced, second-quarter fiscal 2027 results topped expectations and margins expanded.
Management also raised fiscal 2027 revenue and adjusted EBITDA guidance. Still, cybersecurity litigation, regulatory inquiries, competitive pricing pressure and sensitivity of custodial economics to interest rates and contract renewals keep the risk-reward picture balanced after the recent advance.
HQY’s HSA Engine Keeps Building Scale
HealthEquity administered 10.7 million HSAs and $37.9 billion in HSA assets as of July 31, 2026. Those figures were up 8% and 14% year over year, respectively, reinforcing the scale of the company’s core HSA platform.
New HSAs from sales increased 24% in the fiscal second quarter. Client renewals remained on pace to exceed 90% for the year, supporting continued account growth through partner, direct and existing-client channels.
Image Source: Zacks Investment Research
HealthEquity’s Investment Balances Add Momentum
HSAs with investments rose 20% year over year to 939,000, while HSA investment assets increased 28% to $20.6 billion. The faster growth in invested assets points to greater use of the investment side of the platform.
Management said roughly 9% of HealthEquity’s HSA population was investing at quarter-end. Its recently launched SimplyInvest lineup has no administrative fee, giving the company another tool to encourage adoption as accounts mature.
HQY’s Earnings and Margins Strengthen the Setup
Adjusted earnings of $1.24 per share in the fiscal second quarter increased 14.8% year over year and beat the Zacks Consensus Estimate by 4.2%. Revenues rose 7.6% to $350.7 million and exceeded the consensus mark.
Gross margin expanded about 220 basis points to 73.5%, while operating margin improved about 60 basis points to 28.1%. Lower service costs from technology-enabled efficiencies supported the margin gains.
HealthEquity Raises Guidance as Efficiency Improves
HealthEquity raised fiscal 2027 revenue guidance to $1.411-$1.421 billion from $1.410-$1.420 billion. Adjusted EBITDA is now expected to be $628-$636 million, up from the prior $625-$633 million range.
AI resolved 85% of routine chat inquiries and contained 55% of card-related phone contacts in the latest quarter. Human-handled calls declined 25% year over year, while adjusted EBITDA margin reached 48%.
Image Source: Zacks Investment Research
HQY Still Faces Risks After the Recent Rally
The fiscal 2025 cybersecurity incident remains an overhang. HealthEquity is subject to a consolidated putative class action and regulatory inquiries, while the potential loss tied to the matters was not reasonably estimable. Custodial economics also remain sensitive to interest rates and contract renewals.
WEX Inc. (WEX - Free Report) offers HSAs and other consumer-directed benefits and serves as an IRS-designated non-bank HSA custodian. UnitedHealth Group Incorporated (UNH - Free Report) , through Optum Financial and Optum Bank, also operates at scale in health financial accounts. These alternatives underscore competition around pricing, products and partner relationships.
HQY’s Style Scores Support a Balanced View
The recent rally has support from rising HSA scale, deeper investment engagement, better quarterly profitability and higher guidance. The next test is whether HealthEquity can sustain those trends while managing cybersecurity, pricing and interest-rate risks.
HQY currently carries a Zacks Rank #3 (Hold). It has a Growth Score of B, Momentum Score of B and VGM Score of B, while its Value Score of C is less favorable. Style Scores complement the Zacks Rank, and A or B grades are generally more favorable than C. The combination supports a measured view rather than a top-ranked buy signal after the stock’s advance.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.